Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

5619 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
64-1 Verzenios (唯择) Eli Lilly Nederland B.V. Original drug sold in China Original drug imported to China The 64th Batch of Reference Listed Drugs
64-2 Verzenios (唯择) Eli Lilly Nederland B.V. Original drug sold in China Original drug imported to China The 64th Batch of Reference Listed Drugs
64-3 Curosurf (固尔苏) Chiesi Farmaceutici S.p.A. Original drug sold in China Original drug imported to China The 64th Batch of Reference Listed Drugs
64-4 Curosurf (固尔苏) Chiesi Farmaceutici S.p.A. Original drug sold in China Original drug imported to China The 64th Batch of Reference Listed Drugs
64-5 Oracea Galderma Laboratories LP Original drug not imported to China US Orange Book The 64th Batch of Reference Listed Drugs
64-6 Triferic Rockwell Medical, Inc. Original drug not imported to China US Orange Book The 64th Batch of Reference Listed Drugs
64-7 AMYVID AVID RADIOPHARMACEU TICALS INC Original drug not imported to China US Orange Book The 64th Batch of Reference Listed Drugs
64-8 AMYVID AVID RADIOPHARMACEU TICALS INC Original drug not imported to China US Orange Book The 64th Batch of Reference Listed Drugs
64-9 PHEXXI Evofem, Inc. Original drug not imported to China US Orange Book The 64th Batch of Reference Listed Drugs
64-10 / BIONPHARMA INC Original drug not imported to China US Orange Book The 64th Batch of Reference Listed Drugs